Physician profile
Guy E Reyes
NPI 1952586851
$8,423.48
in general payments reported to CMS, 2019-2025
24 companies · $1,425 in 2025
The $1,425 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $353 · 2020: $2,667 · 2021: $19.85 · 2022: $2,606 · 2023: $682 · 2024: $671 · 2025: $1,425.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,024 · Travel and Lodging: $753.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,024.01 |
| Travel and Lodging | $753.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $2,745.69 | 2022-2025 | |
| Arthrex, INC. | $1,962.88 | 2020 | |
| Medical Device Business Services, INC. | $853.40 | 2025 | Motoband |
| Medinc of Texas | $688.13 | 2020-2023 | |
| Acumed LLC | $311.13 | 2024-2025 | Acumed, Acumed |
| Paratek Pharmaceuticals, INC. | $267.41 | 2024-2025 | Nuzyra |
| Stryker Corporation | $256.49 | 2023-2025 | Allograft, Accolade, Insignia |
| Orthofix Medical, INC. | $209.42 | 2019-2025 | Physio-Stim, Spinal-Stim, Cervical-Stim |
| Smith+Nephew, INC. | $175.44 | 2019-2025 | Collagenase Santyl, Pico, Renasys Go V2 Home |
| Mission Medical Distribution, LLC | $147.76 | 2023-2025 | |
| Kerecis Limited | $141.25 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Alexion Pharmaceuticals, INC. | $125.25 | 2019 | |
| Solventum Corporation | $120.13 | 2025 | Activ.A.C. |
| Ibsa Pharma INC. | $88.48 | 2023-2024 | Tirosint, Licart, Flector |
| Shockwave Medical, INC | $75.45 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nvision Biomedical Technologies, INC. | $51.55 | 2022 | |
| Abbott Laboratories | $35.09 | 2019 | |
| Medela LLC | $34.94 | 2019 | |
| Horizon Therapeutics Plc | $32.04 | 2020-2021 | |
| Nevro Corp. | $21.92 | 2024 | Senza |
| Fidia Pharma USA INC. | $21.12 | 2023 | Triluron, Hymovis |
| Integra Lifesciences Corporation | $20.79 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Heron Therapeutics, INC. | $18.95 | 2024 | Zynrelef |
| Mdd US Operations, LLC | $18.77 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Guy Reyes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.